(3S)‐3‐(2,3‐difluorophenyl)‐3‐methoxypyrrolidine (IRL752) —a Novel Cortical-Preferring Catecholamine Transmission- and Cognition-Promoting Agent
- Submitting institution
-
The University of Bradford
- Unit of assessment
- 3 - Allied Health Professions, Dentistry, Nursing and Pharmacy
- Output identifier
- 134
- Type
- D - Journal article
- DOI
-
10.1124/jpet.120.000037
- Title of journal
- Journal of Pharmacology and Experimental Therapeutics
- Article number
- -
- First page
- 404
- Volume
- 374
- Issue
- 3
- ISSN
- 0022-3565
- Open access status
- Compliant
- Month of publication
- -
- Year of publication
- 2020
- URL
-
https://jpet.aspetjournals.org/content/374/3/404
- Supplementary information
-
-
- Request cross-referral to
- -
- Output has been delayed by COVID-19
- No
- COVID-19 affected output statement
- -
- Forensic science
- No
- Criminology
- No
- Interdisciplinary
- No
- Number of additional authors
-
14
- Research group(s)
-
-
- Citation count
- 2
- Proposed double-weighted
- No
- Reserve for an output with double weighting
- No
- Additional information
- -
- Author contribution statement
- Some detail is provided in the author contributions. McLean made significant contributions in planning the cognitive testing experiments i.e. reversal learning and novel object recognition, including experimental design, generating data and performing statistical analysis and interpretation.
McLean contributed to generation of the draft manuscript (particularly the methods and results for the behavioural experiments) and provided comments and critique on the intellectual content within full manuscript before submission. McLean also made relevant contributions to the rebuttal and revised manuscript following reviewers' comments on the first submission.
- Non-English
- No
- English abstract
- -
